Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA #sort descending PI/Project Leader Institution Title Status
2012 R21 RFA-CA-12-002 GRZYBOWSKI, BARTOSZ ANDRZEJ NORTHWESTERN UNIVERSITY MICROSYSTEMS FOR TARGETING LEVY WALKS IN METASTATIC CANCER CELLS Complete
2012 R21 RFA-CA-12-002 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY PCR-FREE MULTIPLEXED DETECTION OF CIRCULATING MIRNA IN BLOOD Complete
2012 R21 RFA-CA-12-002 DAVALOS, RAFAEL VIDAL VIRGINIA POLYTECHNIC INST AND ST UNIV ISOLATION OF TUMOR INITIATING CELLS (TICS) USING CONTACTLESS DIELECTROPHORESIS Complete
2012 R21 RFA-CA-12-002 TAO, NONGJIAN ARIZONA STATE UNIVERSITY-TEMPE CAMPUS CHARGE SENSITIVE OPTICAL DETECTION FOR HIGH THROUGHPUT STUDY OF SMALL MOLECULES Complete
2012 R21 RFA-CA-12-002 CARTEGNI, LUCA SLOAN-KETTERING INST CAN RESEARCH CONTROLLED PREMATURE TERMINATION OF TRANSLATION TO GENERATE DESIGNATED TRUNCATED Complete
2013 R33 RFA-CA-12-003 JI, HANLEE P STANFORD UNIVERSITY OLIGONUCLEOTIDE-SELECTIVE SEQUENCING FOR INTEGRATED AND RAPID CANCER GENOME ANALY Complete
2013 R33 RFA-CA-12-003 KAMM, ROGER D. MASSACHUSETTS INSTITUTE OF TECHNOLOGY MICROFLUIDIC 3D ASSAYS FOR METASTATIC CANCER Complete
2013 R33 RFA-CA-12-003 FURDUI, CRISTINA MARIA WAKE FOREST UNIVERSITY HEALTH SCIENCES NEW REAGENTS FOR TRACKING PROTEIN OXIDATION IN CELLS BY MS AND IMAGING METHODS Complete
2013 R33 RFA-CA-12-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN MESO-PLEX MIRNA AND PROTEIN PROFILING FOR CANCER DIAGNOSTICS USING CHIP-INTEGRATE Complete
2013 R33 RFA-CA-12-003 DI CARLO, DINO UNIVERSITY OF CALIFORNIA LOS ANGELES ISOLATING CIRCULATING TUMOR CELLS USING A CENTRIFUGE ON A CHIP Complete
2013 R33 RFA-CA-12-003 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER ADVANCED DEVELOPMENT OF IMMUNO-MRM TECHNOLOGY TO ANALYZE ARCHIVED CANCER TISSUES Complete
2013 R33 RFA-CA-12-003 TACKETT, ALAN JACKSON UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT OF MASSSQUIRM TO QUANTITATIVELY MEASURE LYSINE METHYLATION Complete
2012 R33 RFA-CA-12-003 ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE ACTIVATABLE ONE-DROP AND ONE-STEP ASSAY FOR CIRCULATING TUMOR CE Complete
2013 R33 RFA-CA-12-003 CUNNINGHAM, BRIAN T. UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN PHOTONIC CRYSTAL ENHANCED FLUORESCENCE: DEVELOPMENT OF SENSORS STRUCTURES AND DET Complete
2012 R33 RFA-CA-12-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS DISCOVERY OF DEATH LIGANDS AGAINST CANCERS Complete
2012 R33 RFA-CA-12-003 NOLLING, JORK N PRIMERADX, INC. A HIGHLY MULTIPLEXED PCR PLATFORM FOR GENE EXPRESSION PROFILING FROM FFPE TISSUE Complete
2013 R21 RFA-CA-12-004 LAI, JAMES UNIVERSITY OF WASHINGTON BIOSPECIMEN PREPARATION TECHNOLOGIES TO ENABLE HIGH THROUGHPUT AND HIGHLY SENSITI Complete
2012 R21 RFA-CA-12-004 JANZEN, WILLIAM PERRY UNIV OF NORTH CAROLINA CHAPEL HILL CAVITATION ENHANCEMENT OF BIOSPECIMEN PROCESSING FOR IMPROVED DNA FRAGMENTATION Complete
2012 R21 RFA-CA-12-004 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA DEVELOPMENT OF ROOM-TEMPERATURE STORAGE TECHNIQUE FOR PLASMA/SERUM BIOSPECIMENS Complete
2013 R33 RFA-CA-12-005 SCHLEGEL, RICHARD GEORGETOWN UNIVERSITY CONDITIONALLY REPROGRAMMED CELLS AS A NOVEL TOOL FOR BIOBANKING Complete
2012 R33 RFA-CA-12-005 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY NANOTRAP TECHNOLOGY FOR ONE STEP PRESERVATION AND AMPLIFICATION OF CANCER BIOMARK Complete
2013 R33 RFA-CA-12-005 TSENG, HSIAN-RONG UNIVERSITY OF CALIFORNIA LOS ANGELES MOLECULAR AND FUNCTIONAL ANALYSIS OF SINGLE CIRCULATING MELANOMA CELLS Complete
2014 R21 RFA-CA-13-001 TEMPST, PAUL SLOAN-KETTERING INST CAN RESEARCH IMMOBILIZED PROTEASE ACTIVITY TESTS FOR DEVELOPING FUNCTIONAL CANCER BIOMARKERS. Complete
2014 R21 RFA-CA-13-001 RIETHMAN, HAROLD WISTAR INSTITUTE A NOVEL SINGLE-MOLECULE TELOMERE CHARACTERIZATION TECHNOLOGY FOR ANALYZING CANCER Complete
2014 R21 RFA-CA-13-001 KUMAR, SANJAY UNIVERSITY OF CALIFORNIA BERKELEY MOLECULAR ANALYSIS OF PHYSICAL MICROENVIRONMENTAL CONTROL OF TUMOR CELL INVASION Complete
2014 R21 RFA-CA-13-001 PETUKHOV, PAVEL A UNIVERSITY OF ILLINOIS AT CHICAGO PHOTOREACTIVE HISTONE DEACETYLASE PROBES FOR CHROMATIN IMMUNOPRECIPITATION IN CAN Complete
2014 R21 RFA-CA-13-001 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY IMPLANTABLE DEVICE FOR HIGH-THROUGHPUT IN VIVO DRUG SENSITIVITY TESTING Complete
2014 R21 RFA-CA-13-001 ZAIA, JOSEPH BOSTON UNIVERSITY MEDICAL CAMPUS QUANTITATIVE PROFILING OF GLYCOSAMINOGLYCANS FROM BREAST TUMOR TISSUE ARRAYS Complete
2014 R21 RFA-CA-13-001 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA A MICRO HALL CHIP FOR CIRCULATING MICROVESICLE BASED CANCER MONITORING Complete
2014 R21 RFA-CA-13-001 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY DIGITAL DETECTION OF TUMOR-DERIVED CIRCULATING METHYLATED DNA Complete
2013 R21 RFA-CA-13-001 CELEDON, ALFREDO ANDRES SCANOGEN, INC. SINGLE MOLECULE MICROARRAYS FOR THE DETECTION OF MUTANT DNA IN BODY FLUIDS Complete
2014 R21 RFA-CA-13-001 CHIU, DANIEL T UNIVERSITY OF WASHINGTON ULTRA-BRIGHT PROBES WITH ULTRA-NARROW EMISSION FOR MOLECULAR AND CELLULAR ANALYSI Complete
2013 R21 RFA-CA-13-001 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES COMPACT MICROFLUIDIC PET PROBE CONCENTRATOR FOR PRECLINICAL AND IN VITRO IMAGING Complete
2014 R21 RFA-CA-13-001 ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE INTEGRATED MICROFLUIDIC EXOSOME PROFILING FOR EARLY DETECTION OF CANCER Complete
2013 R21 RFA-CA-13-001 WANG, ANDREW ZHUANG UNIV OF NORTH CAROLINA CHAPEL HILL DEVELOPMENT OF 3D ORGAN-SPECIFIC MODELS OF COLORECTAL CANCER METASTASIS Complete
2014 R21 RFA-CA-13-001 CHEN, XIAOWEI RESEARCH INST OF FOX CHASE CAN CTR A NOVEL ALLELE-SPECIFIC RNA-ISH FOR DIFFERENTIAL ALLELE-SPECIFIC EXPRESSION Complete
2013 R21 RFA-CA-13-001 CHENG, JI-XIN PURDUE UNIVERSITY QUANTITATIVE SPECTROSCOPIC IMAGING OF CANCER METABOLITES IN LIVE CELLS AND INTACT Complete
2014 R21 RFA-CA-13-001 LEVENSON, RICHARD M. UNIVERSITY OF CALIFORNIA AT DAVIS HIGHLY MULTIPLEXED ION-BEAM TISSUE RNA IN SITU IMAGING WITH SUB-MICRON RESOLUTION Complete
2013 R21 RFA-CA-13-001 LEVY, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE LECTIMERS: GLYCAN-ANCHORED SCAFFOLD LIBRARIES FOR TARGETING CARBOHYDRATE-BINDING Complete
2013 R21 RFA-CA-13-001 OZERS, MARY SZATKOWSKI PROTEOVISTA, LLC HIGH DENSITY PEPTIDE ARRAYS FOR CANCER-RELATED POST-TRANSLATIONAL MODIFICATIONS Complete
2013 R21 RFA-CA-13-001 TAVANA, HOSSEIN UNIVERSITY OF AKRON A NOVEL HIGH THROUGHPUT TUMOR SPHEROID MICROTECHNOLOGY Complete
2013 R21 RFA-CA-13-001 WILSON, JAMES NORBERT UNIVERSITY OF MIAMI CORAL GABLES KINASE BINDING FLUORESCENT PROBES FOR ASSAYING CELLULAR RECEPTOR POPULATIONS Complete
2013 R21 RFA-CA-13-001 WANG, ZHENGHE CASE WESTERN RESERVE UNIVERSITY NEXT-GENERATION MOUSE GENE-TARGETING TECHNOLOGY TO MODEL TUMORIGENESIS Complete
2013 R33 RFA-CA-13-002 KUHN, PETER SCRIPPS RESEARCH INSTITUTE CLINICAL VALIDATION OF THE HD-CTC FLUID BIOPSY IN EARLY DETECTION OF LUNG CANCER. Complete
2013 R33 RFA-CA-13-002 BROWN, BRIAN DAVID ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI SENSOR-SEQ: A GENOME-WIDE BIOLOGICAL MEASURE OF MICRORNA ACTIVITY. Complete
2013 R33 RFA-CA-13-002 HSIAO, SHIH-CHIA ADHEREN, INC. THE DEVELOPMENT OF A MICROSCOPY-BASED CELL-ARRAY TOXICITY ASSAY FOR QUANTIFYING C Complete
2013 R33 RFA-CA-13-002 XIE, XIAOLIANG SUNNEY HARVARD UNIVERSITY WHOLE GENOME AMPLIFICATION AND SEQUENCING OF SINGLE CANCER CELLS Complete
2014 R33 RFA-CA-13-002 WEISS, WILLIAM A UNIVERSITY OF CALIFORNIA, SAN FRANCISCO INTEGRATING MASS CYTOMETRIC AND TRANSCRIPTOMIC PROFILES OF SOLID TUMORS Complete
2014 R33 RFA-CA-13-002 ROBINSON, WILLIAM H STANFORD UNIVERSITY LARGE-SCALE CHARACTERIZATION OF ANTI-CANCER ANTIBODY RESPONSES IN LUNG ADENOCARCI Complete
2014 R33 RFA-CA-13-002 FEDERSPIEL, MARK J MAYO CLINIC ROCHESTER VALIDATING TECHNOLOGY TO OPTIMIZE ANTIBODY AFFINITY FOR TARGETING THERAPEUTICS Complete

Pages